Published in Cancer Weekly, January 26th, 2010
"Many studies have focused on the role of these proteins in modulating drug resistance, but their effect on retention of imaging agents is less well studied. To study the role of MDR1 expression on the accumulation of Cu-64-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-64-ATSM) and Cu-64-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-64-PTSM) in human tumors in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.